4//SEC Filing
LEAP THERAPEUTICS, INC. 4
Accession 0001104659-17-003610
$CYPHCIK 0001509745operating
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 6:13 PM ET
Size
7.9 KB
Accession
0001104659-17-003610
Insider Transaction Report
Form 4
LITTLECHILD JOHN W
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2017-01-23+11,000→ 11,000 totalExercise: $9.90Exp: 2027-01-22→ Common Stock, $0.001 par value per share (11,000 underlying) - Award
Stock Option (Right to Buy)
2017-01-23+15,000→ 15,000 totalExercise: $9.90Exp: 2027-01-22→ Common Stock, $0.001 par value per share (15,000 underlying)
Footnotes (2)
- [F1]The Option was granted pursuant to Leap's Amended and Restated 2012 Equity Incentive Plan and is fully vested as of the grant date.
- [F2]The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 12 equal quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of January 23, 2017, the Vesting Start Date.
Documents
Issuer
LEAP THERAPEUTICS, INC.
CIK 0001509745
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001509745
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 6:13 PM ET
- Size
- 7.9 KB